GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global Vendor Neutral Archive (VNA) Market Size and Trends

The global vendor neutral archive (VNA) market was valued US$ 3.96 Bn in 2023 and is expected to reach US$ 5.93 Bn by 2031 growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.

Global Vendor Neutral Archive (VNA) Market- Trends

• Growing demand for multi-department and multi-site VNA solutions: The demand for Vendor Neutral Archive (VNA) solutions is evolving from single department and single site integrations to multi-department and multi-site implementations. Healthcare organizations are increasingly adopting enterprise-wide imaging strategies to achieve interoperability across specialties and facilities. This enables centralized access and management of medical images and associated data across radiology, cardiology, pathology and other clinical departments under a single solution. VNA systems are helping deliver on this need by supporting the ingestion, consolidation and distribution of studies from multiple modalities, departments and facilities on a unified platform.
• Integration of VNA solutions with hospital information systems: The integration of Vendor Neutral Archive (VNA) solutions with hospital information systems is emerging as a key trend influencing the vendor neutral archive (VNA) market. VNA systems, which allow consolidation and management of medical images and related data irrespective of source, are increasingly being seamlessly integrated with Hospital Information Systems (HIS) and Radiology Information Systems (RIS). This allows centralized access to patient imaging data and related information directly within existing clinical workflows. Healthcare providers are recognizing the value of having a single platform for all diagnostic images and reports across departments. A fully integrated solution allows images and related data to be securely accessed in a standardized format by radiologists, cardiologists, oncologists and other specialists from within their normal HIS/RIS system with relevant clinical context.